- Filed
- Feb 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Sep 30, 2024 | 22M sh |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $437.12K |
| Short Term Investments | Q2 2025 · Mar 31, 2024 | $2.1M |
| Short Term Investments | Q2 2025 · Mar 31, 2023 | $1.46M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $8.65M |
| Current Liabilities | Q2 2025 · Mar 31, 2024 | $7.21M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $10.55M |
| Total Liabilities | Q2 2025 · Mar 31, 2024 | $9.24M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $31.37M |
| Current Assets | Q2 2025 · Mar 31, 2024 | $27.51M |
| Total Assets | Q2 2025 · Mar 31, 2024 | $27.87M |
| Total Assets | Q2 2025 · Sep 30, 2023 | $26.02M |
| Shares Diluted | Q2 2025 · Sep 30, 2023 | 22M sh |
| Capex | Q2 2025 · Sep 30, 2023 | $543 |
| Operating Cash Flow | Q2 2025 · Sep 30, 2023 | −$3.72M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2023 | $2.04M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2023 | $3.39M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $16.37M |
| Stockholders Equity | Q2 2025 · Mar 31, 2023 | $14.82M |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.11 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.11 |
| Sga Expense | Q2 2025 · Sep 30, 2023 | $400.62K |
| Rd Expense | Q2 2025 · Sep 30, 2023 | $102.33K |
| Net Income | Q2 2025 · Sep 30, 2023 | $2.47M |
| Operating Income | Q2 2025 · Sep 30, 2023 | $2.82M |
| Gross Profit | Q2 2025 · Sep 30, 2023 | $3.38M |
| Cost Of Revenue | Q2 2025 · Sep 30, 2023 | $23.12M |
| Revenue | Q2 2025 · Sep 30, 2023 | $26.5M |